摘要 |
The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R<SUP>11 </SUP>and R<SUP>14</SUP>, R<SUP>15</SUP>, R<SUP>16</SUP>, and R<SUP>17 </SUP>are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I. |